Ex Parte RibiDownload PDFPatent Trial and Appeal BoardMar 2, 201713678463 (P.T.A.B. Mar. 2, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/678,463 11/15/2012 Hans O. Ribi SGAN-007CON2 1263 24353 7590 03/06/2017 BOZICEVIC, FIELD & FRANCIS LLP Bozicevic, Field & Francis 201 REDWOOD SHORES PARKWAY SUITE 200 REDWOOD CITY, CA 94065 EXAMINER KHATRI, PRASHANT J ART UNIT PAPER NUMBER 1783 NOTIFICATION DATE DELIVERY MODE 03/06/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): docket@bozpat.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte HANS O. RIBI Appeal 2016-000728 Application 13/678,463 Technology Center 1700 Before ROMULO H. DELMENDO, DONNA M. PRAISS, and DEBRA L. DENNETT, Administrative Patent Judges. DENNETT, Administrative Patent Judge. DECISION ON APPEAL1 1 In our Opinion below, we refer to the Final Action delivered electronically on November 6, 2014 (“Final Act.”); the Advisory Action delivered electronically on February 20, 2015 (“Adv. Act.”); the Appeal Brief filed June 1, 2015 (“App. Br.”); and the Examiner’s Answer delivered electronically on August 14, 2015 (“Ans.”). A Reply Brief was not filed. Appeal 2016-000728 Application 13/678,463 STATEMENT OF THE CASE Appellant2 appeals under 35 U.S.C. § 134(a) from a rejection of claims 1, 4—6, 8—13, and 32-41. Final Act. 4. We have jurisdiction under 35 U.S.C. § 6(b). We REVERSE. The claims are directed to composite materials consisting of a shape memory polymer consisting of a thermoplastic polyurethane that changes shape, and a thermochromic pigment or color change compound that changes color. Claims 1, 37, and 39. Claim 1, reproduced below, is illustrative of the claimed subject matter: 1. A composite material consisting of: (a) a shape memory polymer consisting of a thermoplastic polyurethane that changes shape in response to a first applied stimulus; and (b) a thermochromic pigment that changes color in response to a second applied stimulus. App. Br. 20 (Claims App’x). REFERENCES The Examiner relies on the following prior art in rejecting the claims on appeal: Coran et al. (“Coran”) US 4,141,863 Yee et al. (”Yee”) US 4,215,208 Kamada et al. US 5,208,132 (“Kamada”) Langer et al. US 6,388,043 B1 (“Langer”) 21 C.F.R. § 172.615 (“FDA Rule”) Feb. 27, 1979 July 29, 1980 May 4, 1993 May 14, 2002 2 Appellant identifies the real party in interest as Segan Industries, Inc. App. Br. 3. 2 Appeal 2016-000728 Application 13/678,463 REJECTIONS The Examiner maintains the following rejections under 35 U.S.C. § 103(a): (1) claims 1, 4—6, 8—13, and 32—36 over Langer in view of Yee; (2) claims 37 and 38 over Langer in view of Yee and Kamada; and (3) claims 39-41 over Coran in view of Yee with evidence from FDA Rule. Final Act. 4—6. The Examiner withdrew the rejections of claim 41 under 35 U.S.C. § 112,111 and 2. Adv. Act. 2. OPINION Appellant argues the patentability of independent claim 1 and dependent claims 4—6, 12, 32, and 35—36 as a group (Group I), and separately argues for patentability of other claims dependent on claim 1, specifically, claims 8 and 9 (Group II), claims 10 and 11 (Group III), claim 13 (Group IV), and claims 33 and 34 (Group V). App. Br. 5, 10, 11. Appellant also argues the patentability of claims 37 and 38 (Group VI) and claims 39-41 (Group VII), which do not depend from claim 1. Because all of the Examiner’s claim rejections are founded on at least the improper combination of Langer with Yee (Final Action 4—6), we address our discussion of the claims to claim 1, which is representative of the issue before us. The Examiner finds that Langer discloses a shape memory composition that is a block copolymer consisting of polyester and polyurethane, which is a thermoplastic urethane. Final Act. 4 (citing Langer Abstract, Fig. 5, cols. 5—13, and 17—18). The Examiner further finds that Langer’s composition can include fillers and other additives, but is silent as to the addition of a thermochromic pigment. Id.', Ans. 8. With respect to 3 Appeal 2016-000728 Application 13/678,463 Yee, the Examiner finds that the reference discloses a thermochromic compound wherein polydiacetylene used as a thermochromic pigment allows for different color transitions at different temperatures wherein the compound is disposed in a thermoplastic material. Id. (citing Yee cols. 4— 17). On this basis, the Examiner concludes that it would have been obvious to one of ordinary skill in the art to add thermochromic compounds to the thermoplastic shape memory polymer compositions of Langer in order to provide a color change function. Id. at 5. The Examiner states that [F]or the specific end-use and behavior, one of ordinary skill in the art would have been motivated to add the desired additive for the desired behavior. As such, in order to add a color change feature, one of ordinary skill in the art would have been motivated at add a color change compound to exhibit such a feature. Ans. 8—9. However, the Examiner does not explain why one of ordinary skill in the art would seek to add a thermochromic pigment to a shape memory polymer without using the instant application as a guide. Appellant argues that the Examiner provides no objective motivation to combine Langer and Yee in the manner asserted. App. Br. 6. We agree. “[A] patent composed of several elements is not proved obvious merely by demonstrating that each of its elements was, independently, known in the prior art.” KSR Int’l Co. v. Teleflex, Inc., 550 U.S. 398, 418 (2007). Neither will mere conclusory statements sustain an obviousness rejection; “instead, there must be some articulated reasoning with some rational underpinning to support the legal conclusion of obviousness,” In re Kahn, 441 F,3d 977, 988 (Fed. Cir. 2006). The Examiner must provide an adequate reason for a person of ordinary skill in the art at the time the invention to have modified the reference or combination of references to 4 Appeal 2016-000728 Application 13/678,463 arrive at the claimed invention. See KSR, 550 U.S. at 418 (“[I]t can be important to identify a reason that would have prompted a person of ordinary skill in the relevant field to combine the elements in the way the claimed new invention does.”). In the absence of such an explanation, the rejection must be reversed. In re Kahn, 441 F.3d at 988; In re Rouffet, 149 F.3d 1350, 1358 (Fed. Cir. 1998) (“hindsight” is inferred when the specific understanding or principal within the knowledge of one of ordinary skill in the art leading to the modification of the prior art in order to arrive at appellant’s claimed invention has not been explained); Perfect Web Techs. Inc. v. InfoUSA, Inc., 587 F.3d 1324, 1330 (Fed. Cir. 2009) (“[T]o invoke ‘common sense’ or any other basis for extrapolating from prior art to a conclusion of obviousness, [the factfinder] must articulate its reasoning with sufficient clarity for review.”). Langer is directed to shape memory polymer compositions, especially those that can hold more than one shape in memory, articles of manufacture thereof, and methods of preparation and use thereof. Langer col. 2,1. 66- col. 3,1. 3. As Appellant explains, “[t]o the extent that Langer discloses incorporating any additional components with the shape memory polymers, Langer is specific to the use of the shape memory polymers for implanted biomedical applications and internal use (i.e., inside the body.)” App. Br. 7 (citing Langer col. 15,1. 55—col. 16,1. 20). Langer contains no motivation or reason for one of ordinary skill in the art at the time of the invention to modify the reference by including a thermochromic pigment, which would not be visible inside a body. The burden is on the Examiner to cite evidence in the references or provide articulated reasoning with some rational underpinning to support the 5 Appeal 2016-000728 Application 13/678,463 conclusion of obviousness. See In re Kahn, 441 F.3d at 988. The Examiner has not met this burden. Thus, Appellant persuasively argues that Yee, in combination with Langer, fails to establish a prima facie case of obviousness of claim 1. For the same reasons, the Examiner also fails to establish a prima facie case of obviousness of claims 4—6, 8—13, 32-41. DECISION For the reasons set forth above, we reverse the obviousness rejections of claims 1, 4—6, 8—13, and 32-41. REVERSED 6 Copy with citationCopy as parenthetical citation